Individualized Diets in Patients with Kidney Disease and Kidney Transplants: A Narrative Review
- PMID: 40566549
- PMCID: PMC12194626
- DOI: 10.3390/life15060896
Individualized Diets in Patients with Kidney Disease and Kidney Transplants: A Narrative Review
Abstract
Chronic kidney disease (CKD) is a widespread condition with significant cardiovascular risks and a progression to end-stage kidney failure. In recent years, increasing attention has been paid to the role of dietary interventions as a factor capable of influencing disease trajectory. This review summarizes the current observational and interventional evidence on various dietary approaches in patients with CKD and kidney transplants (KTs), including Mediterranean, plant-based, and low-protein diets. A balanced Mediterranean diet, rich in fruits, vegetables, whole grains, fish, and unsaturated fats, shows promises in improving the prognosis for CKD patients. Plant-based diets, which emphasize legumes, vegetables, and grains while minimizing animal protein, improve blood pressure and the glycemic and lipid control. Low-protein diets (LPDs), typically providing less than 0.6 g/kg/day of protein, may reduce the CKD progression and nitrogen burden, further delaying the initiation of dialysis. In conclusion, diets represent a valuable and underutilized therapeutic strategy in the management of CKD and KTs, influencing disease progression and patient outcomes.
Keywords: alkaline diet; chronic kidney disease; kidney transplant; low-protein diet; mediterranean diet.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Dietary interventions for adults with chronic kidney disease.Cochrane Database Syst Rev. 2017 Apr 23;4(4):CD011998. doi: 10.1002/14651858.CD011998.pub2. Cochrane Database Syst Rev. 2017. PMID: 28434208 Free PMC article.
-
Protein restriction for diabetic kidney disease.Cochrane Database Syst Rev. 2023 Jan 3;1(1):CD014906. doi: 10.1002/14651858.CD014906.pub2. Cochrane Database Syst Rev. 2023. PMID: 36594428 Free PMC article.
-
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210. Health Technol Assess. 2010. PMID: 20441712
-
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3. Cochrane Database Syst Rev. 2023. PMID: 37466151 Free PMC article.
-
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.Cochrane Database Syst Rev. 2018 Sep 24;9(9):CD011798. doi: 10.1002/14651858.CD011798.pub2. Cochrane Database Syst Rev. 2018. PMID: 30246878 Free PMC article.
References
-
- Capelli I., Gasperoni L., Ruggeri M., Donati G., Baraldi O., Sorrenti G., Caletti M.T., Aiello V., Cianciolo G., La Manna G. New mineralocorticoid receptor antagonists: Update on their use in chronic kidney disease and heart failure. J. Nephrol. 2020;33:37–48. doi: 10.1007/s40620-019-00600-7. - DOI - PubMed
-
- Salah H.M., Al’Aref S.J., Khan M.S., Al-Hawwas M., Vallurupalli S., Mehta J.L., Mounsey J.P., Greene S.J., McGuire D.K., Lopes R.D., et al. Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials. Am. Heart J. 2021;232:10–22. doi: 10.1016/j.ahj.2020.10.064. - DOI - PubMed
-
- Minutolo R., Gabbai F.B., Chiodini P., Provenzano M., Borrelli S., Garofalo C., Bellizzi V., Russo D., Conte G., De Nicola L., et al. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies. Am. J. Kidney Dis. 2020;75:30–38. doi: 10.1053/j.ajkd.2019.05.019. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources